AAMU
BMY.RT

Amundi Asset Management US’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Amundi Asset Management US’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-38,357
Closed -$26K – 1601
2020
Q4 		$26K Sell
38,357
-6,282
-14% -$13.4K ﹤0.01% 1453
2020
Q3 		$100K Sell
44,639
-10,894
-20% -$31.1K ﹤0.01% 1426
2020
Q2 		$199K Sell
55,533
-28,791
-34% -$104K ﹤0.01% 1387
2020
Q1 		$320K Sell
84,324
-92,489
-52% -$305K ﹤0.01% 1260
2019
Q4 		$533K Buy
+176,813
New +$460K ﹤0.01% 1334

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $77B AUM 10.33% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Amundi Asset Management US's BMY.RT Position: Q1 2021 in Review

Amundi Asset Management US sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 38,357 shares — an estimated $26K sold.

Amundi Asset Management US first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $533K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Amundi Asset Management US reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Amundi Asset Management US sold 38,357 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $26K.
  • Amundi Asset Management US first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Amundi Asset Management US's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $533K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.